TY - JOUR
T1 - Obesity paradox: is a high body mass index positively influencing survival outcomes in gynecological cancers? A systematic review and meta-analysis
AU - Pavone, Matteo
AU - Goglia, Marta
AU - Taliento, Cristina
AU - Lecointre, Lise
AU - Bizzarri, Nicolò
AU - Fanfani, Francesco
AU - Fagotti, Anna
AU - Scambia, Giovanni
AU - Marescaux, Jacques
AU - Querleu, Denis
AU - Seeliger, Barbara
AU - Akladios, Chérif
PY - 2024
Y1 - 2024
N2 - Objective Obesity represents an exponentially growing preventable disease leading to different health complications, particularly when associated with cancer. In recent years, however, an 'obesity paradox' has been hypothesized where obese individuals affected by cancer counterintuitively show better survival rates. The aim of this systematic review and meta-analysis is to assess whether the prognosis in gynecological malignancies is positively influenced by obesity. Methods This study adheres to PRISMA guidelines and is registered with PROSPERO. Studies reporting the impact of a body mass index (BMI) of >30 kg/m(2) compared with <30 kg/m(2) in patients with gynecological cancers listed in PubMed, Google Scholar and ClinicalTrials.gov were included in the analysis. The Quality Assessment of Diagnostic Accuracy Studies 2 tool (QUADAS-2) was used for quality assessment of the selected articles. Results Twenty-one studies were identified for the meta-analysis, including 14 108 patients with cervical, ovarian, or endometrial cancer. There was no benefit in 5-year overall survival for obese patients compared with non-obese patients (OR 1.2, 95% CI 1.00 to 1.44, p=0.05; I-2=71%). When pooling for cancer sub-groups, there were no statistically significant differences in 5-year overall survival in patients with cervical cancer and 5-year overall survival and progression-free survival in patients with ovarian cancer. For obese women diagnosed with endometrial cancer, a significant decrease of 44% in 5-year overall survival (p=0.01) was found, with no significant difference in 5-year disease-free survival (p=0.78). Conclusion According to the results of the present meta-analysis, a BMI of >= 30 kg/m(2) does not have a positive prognostic effect on survival compared with a BMI of <30 kg/m(2) in women diagnosed with gynecological cancers. The existence of the 'obesity paradox' in other fields, however, suggests the importance of further investigations with prospective studies.
AB - Objective Obesity represents an exponentially growing preventable disease leading to different health complications, particularly when associated with cancer. In recent years, however, an 'obesity paradox' has been hypothesized where obese individuals affected by cancer counterintuitively show better survival rates. The aim of this systematic review and meta-analysis is to assess whether the prognosis in gynecological malignancies is positively influenced by obesity. Methods This study adheres to PRISMA guidelines and is registered with PROSPERO. Studies reporting the impact of a body mass index (BMI) of >30 kg/m(2) compared with <30 kg/m(2) in patients with gynecological cancers listed in PubMed, Google Scholar and ClinicalTrials.gov were included in the analysis. The Quality Assessment of Diagnostic Accuracy Studies 2 tool (QUADAS-2) was used for quality assessment of the selected articles. Results Twenty-one studies were identified for the meta-analysis, including 14 108 patients with cervical, ovarian, or endometrial cancer. There was no benefit in 5-year overall survival for obese patients compared with non-obese patients (OR 1.2, 95% CI 1.00 to 1.44, p=0.05; I-2=71%). When pooling for cancer sub-groups, there were no statistically significant differences in 5-year overall survival in patients with cervical cancer and 5-year overall survival and progression-free survival in patients with ovarian cancer. For obese women diagnosed with endometrial cancer, a significant decrease of 44% in 5-year overall survival (p=0.01) was found, with no significant difference in 5-year disease-free survival (p=0.78). Conclusion According to the results of the present meta-analysis, a BMI of >= 30 kg/m(2) does not have a positive prognostic effect on survival compared with a BMI of <30 kg/m(2) in women diagnosed with gynecological cancers. The existence of the 'obesity paradox' in other fields, however, suggests the importance of further investigations with prospective studies.
KW - Cervical Cancer
KW - Endometrial Neoplasms
KW - Morbid
KW - Obesity
KW - Ovarian Cancer
KW - Cervical Cancer
KW - Endometrial Neoplasms
KW - Morbid
KW - Obesity
KW - Ovarian Cancer
UR - https://publicatt.unicatt.it/handle/10807/284656
UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85191359479&origin=inward
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85191359479&origin=inward
U2 - 10.1136/ijgc-2023-005252
DO - 10.1136/ijgc-2023-005252
M3 - Article
SN - 1048-891X
SP - 1
EP - 10
JO - International Journal of Gynecological Cancer
JF - International Journal of Gynecological Cancer
IS - 1
ER -